Europe Antibiotics Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Drug Class (Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others); Action Mechanism (Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors); and Country
Market Introduction
Antibiotic is a group of medicines that fights bacterial infections, and sometimes protozoan diseases. Moreover, they are used to treat many diseases such as strep throat, urinary tract infections, sinus infections, pneumonia, eye & ear infections, and others. Antibiotics are also called antimicrobials or antibacterial. Afterthe discovery of the antibiotic penicillin in 1920, various other antibiotic compounds have been used to treat several bacterial infections.
Get more information on this report : 
Market Overview and Dynamics
The Europe antibiotics market is expected to reach US$ 15,569.87 million by 2027 from US$ 12,457.70 million in 2019. The market is estimated to grow with a CAGR of 3.1% from 2020 to 2027. Factors driving the market growth areprevalence of infectious diseases and increasing development of generic drugs. However, the tedious and expensive process of antibiotic development and the impact of COVID-19 pandemic are likely to have a negative impact on market growth.
Key Market Segments
By drug class, the cephalosporins segment accounted for the largest market share in the Europeantibioticsmarket in 2019. In terms of action mechanism, cell wall synthesis inhibitors segment is expected to hold the largest share of the antibioticsmarket by 2027.
Major Sources and Companies Listed
Some of the major primary and secondary sources forAntibioticsmarket included in the report are, World Health Organization (WHO), European Medicine Agency (EMA), and others.
Reasons to buy the report
- To understand the antibioticsmarket landscape and identifymarket segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for antibioticsmarket
- Efficiently plan M&A and partnership dealsin antibiotics market by identifying market segments with the most promising probable sales
- Helps to takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form antibioticsmarket
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe region.
EUROPEANTIBIOTICSMARKET SEGMENTATION
By Drug Class
- Cephalosporin
- Penicillin
- Fluoroquinolones
- Macrolides
- Carbapenem
- Aminoglycosides
- Sulfonamides
- Others
By Action Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
By Geography
- Europe
- Italy
- France
- UK
- Germany
- Spain
Company Profiles
- GlaxoSmithKline plc
- Sanofi
- Novartis AG
- Bayer AG
- Pfizer Inc
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Antibiotics Market – By Drug Class
1.3.2 Europe Antibiotics Market – By Action Mechanism
1.3.3 Europe Antibiotics Market – By Country
2. Europe Antibiotics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Antibiotics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Antibiotics Market - Europe PEST Analysis
4.3 Expert Opinion
5. Europe Antibiotics Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Bacterial Infections
5.1.2 Increasing Development of Generic Drugs
5.2 Key Market Restraints
5.2.1 Tedious and Expensive Process of Antibiotic Development
5.3 Market Opportunities
5.3.1 Growing Investments to Combat Antimicrobial Resistance
5.4 Future Trends
5.4.1 Incorporation of Novel Computing Technologies for Antibiotics Discovery
5.5 Impact analysis
6. Antibiotics Market – Europe Analysis
6.1 Europe Antibiotics Market Revenue Forecasts and Analysis
7. Europe Antibiotics Market Analysis And Forecasts To 2027 – By Drug Class
7.1 Overview
7.2 Europe Antibiotics market, By Drug Class 2019 & 2027 (%)
7.2.1 Europe Antibiotics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)
7.3 Sulfonamides
7.3.1 Overview
7.3.2 Europe Sulfonamides Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Aminoglycosides
7.4.1 Overview
7.4.2 Europe Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Carbapenem
7.5.1 Overview
7.5.2 Europe Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Macrolides
7.6.1 Overview
7.6.2 Europe Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Fluoroquinolones
7.7.1 Overview
7.7.2 Europe Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)
7.8 Penicillin
7.8.1 Overview
7.8.2 Europe Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)
7.9 Cephalosporins
7.9.1 Overview
7.9.2 Europe Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)
7.10 Others
7.10.1 Overview
7.10.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Europe Antibiotics Market Analysis – By Action Mechanism
8.1 Overview
8.2 Europe Antibiotics Market, By Action Mechanism 2019-2027 (%)
8.2.1 Europe Antibiotics Market Revenue and Forecasts to 2027, By Action Mechanism (US$ Mn)
8.3 Mycolic Acid Inhibitors
8.3.1 Overview
8.3.2 Europe Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 RNA Synthesis Inhibitors
8.4.1 Overview
8.4.2 Europe RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 DNA Synthesis Inhibitors
8.5.1 Overview
8.5.2 Europe DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Protein Synthesis Inhibitors
8.6.1 Overview
8.6.2 Europe Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Cell Wall Synthesis Inhibitors
8.7.1 Overview
8.7.2 Europe Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Antibiotics Market Revenue and Forecasts To 2027 – Geographical Analysis
9.1 Europe Antibiotics Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 Europe: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 Europe: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.4 Europe: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.5 Europe: Antibiotics Market, by Country, 2018 & 2027 (%)
9.1.6 Germany: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 Germany: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 Germany: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.6.3 Germany: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.7 UK: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 UK: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 UK: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.7.3 UK: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.8 France: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 France: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 France: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.8.3 France: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.9 Spain: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.1 Spain: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.2 Spain: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.9.3 Spain: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.10 Italy: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.1 Italy: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.2 Italy: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.10.3 Italy: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic on Europe Antibiotics Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 GlaxoSmithKline plc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Sanofi
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Novartis AG
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bayer AG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Pfizer Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Antibiotics Market Revenue and Forecasts To 2027, By Drug Class (US$ Mn)
Table 2. Europe Antibiotics Market Revenue and Forecasts To 2027, By Action Mechanism (US$ Mn)
Table 3. Europe Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 4. Europe Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 5. Germany Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 6. Germany Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 7. UK Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 8. UK Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 9. France Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 10. France Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 11. Spain Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 12. Spain Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 13. Italy Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 14. Italy Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 15. Glossary of Terms, Antibiotics Market
LIST OF FIGURES
Figure 1. Antibiotics Market Segmentation
Figure 2. Europe Antibiotics Market Overview
Figure 3. Cephalosporin Segment Held Largest Share of Product in Antibiotics Market
Figure 4. Italy is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Europe Antibiotics Market - Leading Country Markets (US$ Mn)
Figure 6. Antibiotics Market - Europe PEST Analysis
Figure 7. Antibiotics market impact analysis of driver and restraints
Figure 8. Europe Antibiotics market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Europe Antibiotics market, By Drug Class 2019 & 2027 (%)
Figure 10. Europe Sulfonamides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Europe Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Europe Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Europe Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Europe Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Europe Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Europe Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Europe Antibiotics Market, by Action Mechanism 2019 & 2027 (%)
Figure 19. Europe Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Europe RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Europe DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Europe Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Europe Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Europe: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)
Figure 26. Europe Antibiotics Market Revenue and Forecast to 2027 (USD Million)
Figure 27. Europe: Antibiotics Market, by Country, 2018 & 2027 (%)
Figure 28. Germany: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. UK: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. France: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Spain: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Italy: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Impact of Covid-19 Pandemic In Europe Country Markets
The List of Companies - Europe Antibiotics Market
- GlaxoSmithKline plc
- Sanofi
- Novartis AG
- Bayer AG
- Pfizer Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Antibiotics Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.